Photobiomodulation (PBM), the therapeutic use of low intensity light, typically in the visible and infrared (IR) wavelengths, has been demonstrated to be efficacious in the treatment and prevention of numerous skin conditions. The PBM biological response begins with chromophores, photon accepting molecules which convert light into signals that can stimulate certain biological processes. Important chromophores initiating the PBM response are Cytochrome C Oxidase (CCO), with absorption peaks in the red and near IR wavelengths, opsins absorbing blue and green wavelengths and intracellular water acting at specific sites in the cell. PBM can activate cell signaling processes. The increase in electron transport, oxygen consumption, mitochondrial membrane potential, and ATP synthesis, particularly in hypoxic or stressed cells, can lead to the up-regulation of cell repair and survival pathways. In PBM, the light delivery parameters which maximize the therapeutic response are defined within specific ranges, with total fluence and irradiance being of particular importance. PBM emerges as a valuable complementary treatment modality in dermatology. In terms of tissue repair, wound healing is accelerated by PBM. Cutaneous wounds, erosive mucositis in oncology, leg ulcers, as well as burns and radiodermatitis all benefit from PBM treatment. Widely used to accelerate healing after aggressive aesthetic treatments, PBM reduces inflammation following treatments like skin resurfacing, vascular and benign pigmented lesions, or chemical peels. It has also been shown to be effective in treating dyspigmentation. In the case of hyperpigmentation, melanin synthesis is inhibited with IR light. Additionally, PBM has shown benefits in the treatment of acne and the prevention / treatment of hypertrophic scars. It has shown promise in skin rejuvenation, the treatment of alopecia, cellulite, as well as other skin diseases. The discovery of new applications for PBM, already an effective form of treatment and prevention for many skin conditions, is continually expanding.
Introduction
Human skin is able to absorb the energy of light like a plant and this is not limited to ultraviolet. Indeed, visible and infrared light can also be absorbed, modulating certain cell signaling pathways favorable to the dynamic cutaneous environment. Although the morning and late afternoon sun provide these wavelengths more abundantly, this spectrum can be artificially reproduced using low intensity light. Among the energy- (musculoskeletal, neurological, etc.) , in this review article, we will limit the discussion to the dermatological effects.
PBM's Mechanism of Action
The electromagnetic radiation wavelength range of PBM is essentially between 400
and 1200 nm. Red (600-700 nm) and near- 
Ion Channels and Opsins
This is a new class of photoreceptor that responds in the spectrum of blue and green. The optimal effect of reducing redness and edema would occur on day four postaggression. There have been studies attempting to refute PBM. For example, Boulos et al. (62) showed multiple biases which could not have allowed for the conclusions drawn. acnes and red for inflammatory acne lesions) has a high therapeutic potential.
Besides, the integration of small HUD will likely change the way we approach this frequent dermatological problem.
Alopecia
There are already many FDA cleared PBM devices on the market that emit red for the treatment of Androgenetic Alopecia (AGA).
These can be found in combs, caps, helmets, 
